What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q2 2017?

115 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 27,265,524
Share change: +6,737,615
Total reported value: $391,622,872
Put/Call ratio: 35%
Price per share: $14.37
Number of holders: 115
Value change: +$102,455,955
Number of buys: 79
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
EAGLE ASSET MANAGEMENT INC	13F	Company	1.3%	3,550,547	$32,665,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	1%	2,688,072	$24,730,000	—	31 Mar 2017	13F
Nantahala Capital Management, LLC	13F	Company	0.87%	2,280,531	$20,981,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	0.49%	1,301,880	$11,977,000	—	31 Mar 2017	13F
Novo Holdings A/S	13F	Company	0.48%	1,272,247	$11,705,000	—	31 Mar 2017	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.39%	1,038,500	$9,554,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	0.35%	931,855	$8,573,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.33%	870,442	$8,008,000	—	31 Mar 2017	13F
Marshall Wace North America L.P.	13F	Company	0.26%	692,496	$6,232,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.21%	547,728	$5,038,000	—	31 Mar 2017	13F
Avoro Capital Advisors LLC	13F	Company	0.17%	456,369	$4,199,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.16%	430,314	$3,959,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.15%	401,158	$3,692,000	—	31 Mar 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.15%	386,267	$3,554,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.14%	368,330	$3,389,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	330,096	$3,036,000	—	31 Mar 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.11%	296,559	$2,727,000	—	31 Mar 2017	13F
FT Options LLC	13F	Company	0.11%	286,477	$2,636,000	—	31 Mar 2017	13F
City Financial Investment Co Ltd	13F	Company	0.07%	188,998	$1,739,000	—	31 Mar 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.06%	152,020	$1,399,000	—	31 Mar 2017	13F
UBS Group AG	13F	Company	0.06%	151,646	$1,395,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.06%	146,806	$1,350,000	—	31 Mar 2017	13F
Segantii Capital Management Ltd	13F	Company	0.05%	141,157	$1,299,000	—	31 Mar 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	125,130	$1,152,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	103,183	$949,000	—	31 Mar 2017	13F
TFS CAPITAL LLC	13F	Company	0.03%	90,854	$836,000	—	31 Mar 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.03%	89,467	$823,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	87,236	$802,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	70,742	$651,000	—	31 Mar 2017	13F
DAFNA Capital Management LLC	13F	Company	0.03%	70,455	$648,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	65,585	$603,000	—	31 Mar 2017	13F
JOHNSON INVESTMENT COUNSEL INC	13F	Company	0.02%	65,392	$601,000	—	31 Mar 2017	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	65,000	$598,000	—	31 Mar 2017	13F
Piermont Capital Management Inc.	13F	Company	0.02%	64,655	$595,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.02%	63,804	$587,000	—	31 Mar 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	59,000	$543,000	—	31 Mar 2017	13F
MARSHALL WACE, LLP	13F	Company	0.02%	52,717	$474,000	—	31 Mar 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.02%	49,624	$457,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	49,277	$453,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	48,101	$443,000	—	31 Mar 2017	13F
Opus Point Partners Management, LLC	13F	Company	0.02%	42,019	$387,000	—	31 Mar 2017	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	40,992	$377,000	—	31 Mar 2017	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.02%	40,176	$370,000	—	31 Mar 2017	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.01%	35,998	$331,000	—	31 Mar 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.01%	35,572	$327,000	—	31 Mar 2017	13F
ALPS ADVISORS INC	13F	Company	0.01%	32,970	$303,000	—	31 Mar 2017	13F
SECOR Capital Advisors, LP	13F	Company	0.01%	32,233	$297,000	—	31 Mar 2017	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.01%	31,340	$288,000	—	31 Mar 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	30,379	$279,000	—	31 Mar 2017	13F
Bryn Mawr Trust Advisors, LLC	13F	Company	0.01%	29,000	$267,000	—	31 Mar 2017	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2017

As of 30 Jun 2017, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,265,524 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, BlackRock Inc., Nantahala Capital Management, LLC, Novo Holdings A/S, VANGUARD GROUP INC, FIRST MANHATTAN CO, PERCEPTIVE ADVISORS LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. This page lists 115 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

115

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.